CURB-65 and SMRT-CO in the prediction of early transfers to the intensive care unit among patients with community-acquired pneumonia initially admitted to a general ward

Journal of Hospital Medicine

Volumn 6, Issue 9, 2011, Pages 513-518

  Huaman, Moises A ^a   Diaz Kuan, Alicia ^a   Hegab, Sara ^a   Brar, Indira ^a,b   Kaatz, Scott ^a  

^a HENRY FORD HOSPITAL   (United States)

^b Henry Ford Health System Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UREA;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BREATHING RATE; CASE CONTROL STUDY; CONFUSION; CONTROLLED STUDY; CURB 65 SCORE; EMERGENCY WARD; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OXYGENATION; PATIENT TRANSPORT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SMRT CO SCORE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; THORAX RADIOGRAPHY; WARD;

AREA UNDER CURVE; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CONFIDENCE INTERVALS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT TRANSFER; PATIENTS' ROOMS; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 82955162549     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.921     Document Type: Article

References (18)

1. Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: Final data for 2005. Natl Vital Stat Rep. 2008; 56( 10): 1-120.
2. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996; 275( 2): 134-141.
3. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001; 163( 7): 1730-1754.
4. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336( 4): 243-250.
5. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax. 2003; 58( 5): 377-382.
6. Charles PG, Wolfe R, Whitby M, et al. SMART-COP: A tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008; 47( 3): 375-384.
7. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000; 31( 2): 347-382.
8. Yandiola PP, Capelastegui A, Quintana J, et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest. 2009; 135( 6): 1572-1579.
9. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44( suppl 2): S27-S72.
10. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med. 2006; 174( 1): 84-93.
11. Masia M, Gutierrez F, Shum C, et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest. 2005; 128( 4): 2223-2229.
12. Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med. 2008; 52( 1): 48-58.
13. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008; 121( 3): 219-225.
14. Niederman MS. Making sense of scoring systems in community acquired pneumonia. Respirology. 2009; 14( 3): 327-335.
15. Saka G, Kreke JE, Schaefer AJ, Chang CC, Roberts MS, Angus DC. Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis. Crit Care. 2007; 11( 3): R65.
16. Chalfin DB, Trzeciak S, Likourezos A, Baumann BM, Dellinger RP. Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit. Crit Care Med. 2007; 35( 6): 1477-1483.
17. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004; 164( 6): 637-644.
18. Paganin F, Lilienthal F, Bourdin A, et al. Severe community-acquired pneumonia: Assessment of microbial aetiology as mortality factor. Eur Respir J. 2004; 24( 5): 779-785.